| The updated landscape of tumor microenvironment and drug repurposing MZ Jin, WL Jin Signal transduction and targeted therapy 5 (1), 166, 2020 | 954 | 2020 |
| Inhibition of SRGAP2 function by its human-specific paralogs induces neoteny during spine maturation C Charrier, K Joshi, J Coutinho-Budd, JE Kim, N Lambert, J De Marchena, ... Cell 149 (4), 923-935, 2012 | 493 | 2012 |
| The F-BAR domain of srGAP2 induces membrane protrusions required for neuronal migration and morphogenesis S Guerrier, J Coutinho-Budd, T Sassa, A Gresset, NV Jordan, K Chen, ... Cell 138 (5), 990-1004, 2009 | 418 | 2009 |
| EAT1 promotes tapetal cell death by regulating aspartic proteases during male reproductive development in rice N Niu, W Liang, X Yang, W Jin, ZA Wilson, J Hu, D Zhang Nature communications 4 (1), 1445, 2013 | 344 | 2013 |
| Statins: a repurposed drug to fight cancer W Jiang, JW Hu, XR He, WL Jin, XY He Journal of Experimental & Clinical Cancer Research 40, 1-33, 2021 | 279 | 2021 |
| Immunotherapy for ovarian cancer: adjuvant, combination, and neoadjuvant C Yang, BR Xia, ZC Zhang, YJ Zhang, G Lou, WL Jin Frontiers in immunology 11, 577869, 2020 | 265 | 2020 |
| MicroRNA-218 Inhibits Glioma Invasion, Migration, Proliferation, and Cancer Stem-like Cell Self-Renewal by Targeting the Polycomb Group Gene Bmi1 Y Tu, X Gao, G Li, H Fu, D Cui, H Liu, W Jin, Y Zhang Cancer research 73 (19), 6046-6055, 2013 | 263 | 2013 |
| Reprogramming of the tumor in the hypoxic niche: the emerging concept and associated therapeutic strategies GZ Qiu, MZ Jin, JX Dai, W Sun, JH Feng, WL Jin Trends in pharmacological sciences 38 (8), 669-686, 2017 | 212 | 2017 |
| B7-H3/CD276: an emerging cancer immunotherapy WT Zhou, WL Jin Frontiers in immunology 12, 701006, 2021 | 204 | 2021 |
| Amyloid-β1–42 oligomer accelerates senescence in adult hippocampal neural stem/progenitor cells via formylpeptide receptor 2 N He, WL Jin, KH Lok, Y Wang, M Yin, ZJ Wang Cell death & disease 4 (11), e924-e924, 2013 | 162 | 2013 |
| Cytokine-induced killer cells as pharmacological tools for cancer immunotherapy X Gao, Y Mi, NA Guo, H Xu, L Xu, X Gou, W Jin Frontiers in immunology 8, 774, 2017 | 161 | 2017 |
| Circulating MiR-16-5p and MiR-19b-3p as two novel potential biomarkers to indicate progression of gastric cancer J Zhang, Y Song, C Zhang, X Zhi, H Fu, Y Ma, Y Chen, F Pan, K Wang, ... Theranostics 5 (7), 733, 2015 | 161 | 2015 |
| Immunotherapy for malignant glioma: current status and future directions H Wang, T Xu, Q Huang, W Jin, J Chen Trends in pharmacological sciences 41 (2), 123-138, 2020 | 135 | 2020 |
| Baicalein Exerts Neuroprotective Effects in FeCl3-Induced Posttraumatic Epileptic Seizures via Suppressing Ferroptosis Q Li, QQ Li, JN Jia, QY Sun, HH Zhou, WL Jin, XY Mao Frontiers in Pharmacology 10, 638, 2019 | 131 | 2019 |
| Circulating tumor cells in precision oncology: Clinical applications in liquid biopsy and 3D organoid model C Yang, BR Xia, WL Jin, G Lou Cancer cell international 19, 1-13, 2019 | 125 | 2019 |
| NAT10 promotes gastric cancer metastasis via N4-acetylated COL5A1 Y Zhang, Y Jing, Y Wang, J Tang, X Zhu, WL Jin, Y Wang, W Yuan, X Li, ... Signal transduction and targeted therapy 6 (1), 173, 2021 | 121 | 2021 |
| Microglia in neurodegenerative diseases Y Xu, MZ Jin, ZY Yang, WL Jin Neural Regeneration Research 16 (2), 270-280, 2021 | 121 | 2021 |
| The emerging role of myeloid-derived suppressor cells in the glioma immune suppressive microenvironment Y Mi, N Guo, J Luan, J Cheng, Z Hu, P Jiang, W Jin, X Gao Frontiers in Immunology 11, 737, 2020 | 121 | 2020 |
| Probiotics, prebiotics, and postbiotics in health and disease J Ji, W Jin, SJ Liu, Z Jiao, X Li MedComm 4 (6), e420, 2023 | 117 | 2023 |
| POH1 deubiquitylates and stabilizes E2F1 to promote tumour formation B Wang, A Ma, L Zhang, WL Jin, Y Qian, G Xu, B Qiu, Z Yang, Y Liu, Q Xia, ... Nature communications 6 (1), 8704, 2015 | 109 | 2015 |
Ming-Zhu JinShanghai Jiao Tong University School of Medicine確認したメール アドレス: shsmu.edu.cn
